Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2014

01-03-2014 | Original Paper

Cervical Cancer Screening Adherence among HIV-Positive Female Smokers from a Comprehensive HIV Clinic

Authors: Faith E. Fletcher, Damon J. Vidrine, Irene Tami-Maury, Heather E. Danysh, Rachel Marks King, Meredith Buchberg, Roberto C. Arduino, Ellen R. Gritz

Published in: AIDS and Behavior | Issue 3/2014

Login to get access

Abstract

HIV-positive women are at elevated risk for developing cervical cancer. While emerging research suggests that gynecologic health care is underutilized by HIV-positive women, factors associated with adherence to Pap testing, especially among HIV-positive female smokers are not well known. We utilized baseline data from a smoking cessation trial and electronic medical records to assess Pap smear screening prevalence and the associated characteristics among the HIV-positive female participants (n = 138). 46 % of the women had at least 1 Pap test in the year following study enrollment. Multiple logistic regression analysis indicated that younger age, African American race, hazardous drinking, increased number of cigarettes smoked per day, and smoking risk perception were associated with non-adherence to Pap smear screening. Cervical cancer screening was severely underutilized by women in this study. Findings underscore the importance of identifying predictors of non-adherence and addressing multiple risk factors and behavioral patterns among HIV-positive women who smoke.
Literature
1.
Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031–7.PubMedCrossRef
2.
Wright TC Jr, Ellerbrock TV, Chiasson MA, van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol. 1994;84(4):591–7.PubMed
3.
Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132(2):277–84.PubMedCrossRef
4.
Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97(8):577–86.PubMedCrossRef
5.
Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 1996;87(3):338–44.PubMedCrossRef
6.
Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR4):1–198.
7.
Oster AM, Sullivan PS, Blair JM. Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr. 2009;51(4):430–6.PubMedCrossRef
8.
Tello MA, Jenckes M, Gaver J, Anderson JR, Moore RD, Chander G. Barriers to recommended gynecologic care in an urban United States HIV clinic. J Womens Health (Larchmt). 2010;19(8):1511–8.PubMedCentralCrossRef
9.
Tello MA, Yeh HC, Keller JM, Beach MC, Anderson JR, Moore RD. HIV women’s health: a study of gynecological healthcare service utilization in a U.S. urban clinic population. J Womens Health (Larchmt). 2008;17(10):1609–14.PubMedCentralCrossRef
10.
Baranoski AS, Horsburgh CR, Cupples LA, Aschengrau A. Stier EA. J Womens Health (Larchmt): Risk Factors for Nonadherence with Pap Testing in HIV-Infected Women; 2011.
11.
Dal Maso L, Franceschi S, Lise M, De’ Bianchi PS, Polesel J, Ghinelli F, et al. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010;10:310.PubMedCentralPubMedCrossRef
12.
Stein MD, Cunningham WE, Nakazono T, Turner BJ, Andersen RM, Bozzette SA, et al. Screening for cervical cancer in HIV-infected women receiving care in the United States. J Acquir Immune Defic Syndr. 2001;27(5):463–6.PubMedCrossRef
13.
Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States. J Womens Health (Larchmt). 2010;19(4):709–12.PubMedCentralCrossRef
14.
Leece P, Kendall C, Touchie C, Pottie K, Angel JB, Jaffey J. Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic. Can Fam Physician. 2010;56(12):e425–31.PubMedCentralPubMed
15.
Keiser O, de Martinez B, Wunder D, Chapuis-Taillard C, Zellweger C, Zinkernagel AS, et al. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. J Acquir Immune Defic Syndr. 2006;43(5):550–5.PubMedCrossRef
16.
Logan JL, Khambaty MQ, D’Souza KM, Menezes LJ. Cervical cancer screening among HIV-infected women in a health department setting. AIDS Patient Care STDS. 2010;24(8):471–5.PubMedCrossRef
17.
Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511–22.PubMedCrossRef
18.
Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1):71–7.PubMedCrossRef
19.
Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care & STDs. 2002;16(1):39–42.CrossRef
20.
Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV + men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30(5):371–83.PubMedCentralPubMedCrossRef
21.
Goldberg D, Weber KM, Orsi J, Hessol NA, D’Souza G, Watts DH, et al. Smoking cessation among women with and at risk for HIV: are they quitting? J Gen Intern Med. 2010;25(1):39–44.PubMedCentralPubMedCrossRef
22.
Henrica CWdV, Sturmans F, Knipschild PG. The role of cigarette smoking in the etiology of cervical dysplasia. Epidemiology. 1994;5(6):631–3.CrossRef
23.
Winkelstein W Jr. Smoking and cervical cancer–current status: a review. Am J Epidemiol. 1990;131(6):945–57 Discussion 58–60.PubMed
24.
25.
26.
Greenwood GL, Paul JP, Pollack LM, Binson D, Catania JA, Chang J, et al. Tobacco use and cessation among a household-based sample of US urban men who have sex with men. Am J Public Health. 2005;95(1):145–51.PubMedCentralPubMedCrossRef
27.
Degenhardt L, Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being. Nicotine Tob Res. 2001;3(3):225–34.PubMedCrossRef
28.
29.
Marks King R, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC. Factors associated with non adherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS. 2012;26(8):479–85.PubMedCentralCrossRef
30.
Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.PubMedCentralPubMedCrossRef
31.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804.PubMedCrossRef
32.
Boarts JM, Bogart LM, Tabak MA, Armelie AP, Delahanty DL. Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study. J Behav Med. 2008;31:445–51.PubMedCrossRef
33.
Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74–81.PubMedCrossRef
34.
Schackman BR, Ribaudo HJ, Krambrink A, Hughes V, Kuritzkes DR, Gulick RM. Racial differences in virologic failure associated with adherence and quality of life on Efavirenz-containing regimens for initial therapy results of ACTG A5095. J Acquir Immune Defic Syndr. 2007;46(5):547–54.PubMedCrossRef
35.
Gonzalez JS, Penedo FJ, Antoni MH, Duran RE, McPherson-Baker S, Ironson G, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23(4):413–8.PubMedCrossRef
36.
Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the ACCTG Adherence Instruments. AIDS Care. 2000;12(2):255–66.PubMedCrossRef
37.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96.PubMedCrossRef
38.
Cohen S, Lichtenstein E. Perceived stress, quitting smoking, and smoking relapse. Health Psychol. 1990;9(4):466–78.PubMedCrossRef
39.
Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15(3):271–83.PubMedCrossRef
40.
Spielberger C, Gorsuch R, Lushene R. STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
41.
Smith RC, Lay CD. State and trait anxiety: an annotated bibliography. Psychol Rep. (Bibliography Rev). 1974;34(2):519–94.
42.
Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
43.
Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm. 2000;57(4):376–86 Quiz 87–89.PubMed
44.
Brewer NT, Weinstein ND, Cuite CL, Herrington JE. Risk perceptions and their relation to risk behavior. Ann Behav Med. [Research Support, Non-U.S. Gov’t]. 2004;27(2):125–30.CrossRef
45.
46.
Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res. 1997;6(6):531–54.PubMedCrossRef
47.
Remor E. Psychometric properties of a European Spanish version of the perceived stress scale (PSS). Span J Psychol. 2006;9(1):86–93.PubMed
48.
Cohen S, Mermelstein R, Kamarck T, Hoberman HM. Measuring the functional components of social support. In: Sarason IG, Sarason BR, editors. Social support: Theory, research, and applications. The Hague, The Netherlands: Martinus Nijhoff; 1985. p. 73–94.CrossRef
49.
Williams DR, Yu Y, Jackson JS, Anderson NB. Racial differences in physical and mental health. J Health Psychol. 1997;2(3):335–51.PubMedCrossRef
50.
Reynolds NR, Neidig JL, Wu AW, Gifford AL, Holmes WC. Balancing disfigurement and fear of disease progression: patient perceptions of HIV body fat redistribution. AIDS Care. 2006;18(7):663–73.PubMedCrossRef
51.
Zaragoza-Macias E, Cosco D, Nguyen ML, Del Rio C, Lennox J. Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Res Hum Retrovir. [Research Support, N.I.H., Extramural]. 2010;26(2):133–8.CrossRef
52.
Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2(3):261–70.PubMed
53.
Cinciripini PM, C. G. Development and validation of a coping skills scale for smoking cessation. Society for Research on Nicotine and Tobacco Annual Meeting; Washington, DC1996.
54.
Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ, Van Vunakis H. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. J Clin Psychopharmacol. 1995;15(3):182–91.PubMedCrossRef
55.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.PubMedCrossRef
56.
57.
Erlen JA, Sereika SM, Cook RL, Hunt SC. Adherence to antiretroviral therapy among women with HIV infection. J Obstet Gynecol Neonatal Nurs. 2002;31(4):470–7.PubMedCrossRef
58.
Raveis VH, Karus DG, Siegel K. Correlates of depressive symptomatology among adult daughter caregivers of a parent with cancer. Cancer. 1998;83(8):1652–63.PubMedCrossRef
59.
Solomon L, Stein M, Flynn C, Schuman P, Schoenbaum E, Moore J, et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17(3):253–61.PubMedCrossRef
60.
Tufts KA, Wessell J, Kearney T. Self-care behaviors of African American women living with HIV: a qualitative perspective. J Assoc Nurses AIDS Care. 2010;21(1):36–52.PubMedCrossRef
61.
Kempf MC, McLeod J, Boehme AK, Walcott MW, Wright L, Seal P, et al. A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions. AIDS Patient Care STDS. 2010;24(8):515–20.PubMedCrossRef
62.
Moneyham L, McLeod J, Boehme A, Wright L, Mugavero M, Seal P, et al. Perceived barriers to HIV care among HIV-infected women in the Deep South. J Assoc Nurses AIDS Care. 2010;21(6):467–77.PubMedCrossRef
63.
Shubert V, Bernstine N. Moving from fact to policy: housing is HIV prevention and health care. AIDS Behav. 2007;11(6 Suppl):172–81.PubMedCrossRef
64.
Watkins-Hayes C, Pittman-Gay L, Beaman J. ‘Dying from’ to ‘living with’: framing institutions and the coping processes of African American women living with HIV/AIDS. Soc Sci Med. 2012;74(12):2028–36.PubMedCrossRef
65.
Cohen DA, Scribner RA, Farley TA. A structural model of health behavior: a pragmatic approach to explain and influence health behaviors at the population level. Prev Med. 2000;30(2):146–54.PubMedCrossRef
66.
Blankenship KM, Friedman SR, Dworkin S, Mantell JE. Structural interventions: concepts, challenges and opportunities for research. J Urban Health. 2006;83(1):59–72.PubMedCentralPubMedCrossRef
67.
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516–42.PubMedCrossRef
68.
MacLaughlan SD, Lachance JA, Gjelsvik A. Correlation between smoking status and cervical cancer screening: a cross-sectional study. J Low Genit Tract Dis. 2011;15(2):114–9.PubMedCrossRef
69.
Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis. 2004;1(1):A04.PubMedCentralPubMed
70.
Simoes EJ, Newschaffer CJ, Hagdrup N, Ali-Abarghoui F, Tao X, Mack N, et al. Predictors of compliance with recommended cervical cancer screening schedule: a population-based study. J Community Health. 1999;24(2):115–30.PubMedCrossRef
71.
Byrne MM, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, et al. Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol. 2010;34(5):611–7.PubMedCrossRef
72.
Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Public Health. 2006;96(6):1060–5.PubMedCentralPubMedCrossRef
73.
Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4):731–6.PubMedCrossRef
74.
Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. AIDS Educ Prev. 2009;21(3 Suppl):94–105.PubMedCrossRef
75.
King RM, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS. 2012;26(8):479–85.PubMedCrossRef
76.
Kendzor DE, Costello TJ, Li Y, Vidrine JI, Mazas CA, Reitzel LR, et al. Race/ethnicity and multiple cancer risk factors among individuals seeking smoking cessation treatment. Cancer Epidemiol Biomarkers Prev. 2008;17(11):2937–45.PubMedCrossRef
77.
Faeh D, Viswanathan B, Chiolero A, Warren W, Bovet P. Clustering of smoking, alcohol drinking and cannabis use in adolescents in a rapidly developing country. BMC Public Health. 2006;6:169.PubMedCentralPubMedCrossRef
78.
Emmons KM, Marcus BH, Linnan L, Rossi JS, Abrams DB. Mechanisms in multiple risk factor interventions: smoking, physical activity, and dietary fat intake among manufacturing workers. Working Well Research Group. Prev Med. 1994;23(4):481–9.PubMedCrossRef
79.
Peek ME, Sayad JV, Markwardt R. Fear, fatalism and breast cancer screening in low-income African-American women: the role of clinicians and the health care system. J Gen Intern Med. 2008;23(11):1847–53.PubMedCentralPubMedCrossRef
80.
Borrelli B, Hayes RB, Dunsiger S, Fava JL. Risk perception and smoking behavior in medically ill smokers: a prospective study. Addiction. 2010;105(6):1100–8.PubMedCentralPubMedCrossRef
81.
Drew EM, Schoenberg NE. Deconstructing fatalism: ethnographic perspectives on women’s decision making about cancer prevention and treatment. Med Anthropol Q. 2011;25(2):164–82.PubMedCentralPubMedCrossRef
82.
Glasgow RE, Orleans CT, Wagner EH. Does the chronic care model serve also as a template for improving prevention? Milbank Q. 2001;79(4):579–612 IV–V.PubMedCentralPubMedCrossRef
83.
Goldstein MG, Whitlock EP, DePue J. Multiple behavioral risk factor interventions in primary care: Summary of research evidence. Am J Prev Med. 2004;27(2 Supplement):61–79.PubMedCrossRef
84.
85.
Drach L, Holbert T, Maher J, Fox V, Schubert S, Saddler LC. Integrating smoking cessation into HIV care. AIDS Patient Care STDS. 2010;24(3):139–40.PubMedCrossRef
86.
Metadata
Title
Cervical Cancer Screening Adherence among HIV-Positive Female Smokers from a Comprehensive HIV Clinic
Authors
Faith E. Fletcher
Damon J. Vidrine
Irene Tami-Maury
Heather E. Danysh
Rachel Marks King
Meredith Buchberg
Roberto C. Arduino
Ellen R. Gritz
Publication date
01-03-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0480-6

Other articles of this Issue 3/2014

AIDS and Behavior 3/2014 Go to the issue

Original Paper

The Role of Parenting in Affecting the Behavior and Adaptive Functioning of Young Children of HIV-Infected Mothers in South Africa

Original Paper

Transition to Injection Drug Use: The Role of Initiators

Original Paper

Anal Sex, Vaginal Sex and HIV Risk Among Female Sex Workers in Papua New Guinea

Brief Report

Social Network Structure and HIV Infection Among Injecting Drug Users in Lithuania: Gatekeepers as Bridges of Infection

Original Paper

Whoonga: Potential Recreational Use of HIV Antiretroviral Medication in South Africa

Original Paper

Associations of Sex Trafficking History with Recent Sexual Risk among HIV-Infected FSWs in India
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits